Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.E. Inzucchi, F. Comite, G.N. Burrow.
Graves’ disease and pregnancy.
Endocr Pract, 1 (1995), pp. 186-192
[2.]
J.H. Mestman.
Hyperthyroidism in pregnancy.
Endocrinol Metab Clin North Am, 27 (1998), pp. 127-149
[3.]
D. Glinoer.
Thyroid hyperfunction during pregnancy.
Thyroid, 8 (1998), pp. 859-864
[4.]
T.M. Goodwin, J.M. Hershman.
Hyperthyroidism due to inappropriate production of human chorionic gonadotropin.
Clin Obstet Gynecol, 40 (1997), pp. 32-44
[5.]
J.P. Grun, S. Meuris, P. De Nayer, D. Glinoer.
The thyrotrophic role of human chorionic gonadotropin (hCG) in the early stages of twin (versus single) pregnancies.
Clin Endocrinol, 46 (1997), pp. 719-725
[6.]
J.M. Hershman.
Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors.
Thyroid, 9 (1999), pp. 653-657
[7.]
J.M. Hershman, H.P. Higgings.
Hydatidiform mole-a cause of clinical hyperthyroidsm.
N Engl J Med, 284 (1971), pp. 573-577
[8.]
U.S. Massiukiewicz, G.N. Burrow.
Hyperthyroidism in pregnancy: diagnosis and treatment.
Thyroid, 9 (1992), pp. 647-652
[9.]
G.N. Burrow.
Thyroid function and hyperfunction during gestation.
Endocr Rev, 14 (1993), pp. 193-202
[10.]
N. Amino, O. Tanizawa, H. Mori, Y. Iwatani, T. Yamada, K. Kurachi, et al.
Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves ’ disease.
J Clin Endocrinol Metab, 55 (1982), pp. 108-112
[11.]
J.I. Hamburger.
Management of hyperthyroidism in children and adolescents.
J Clin Endocrinol Metab, 60 (1985), pp. 1019-1024
[12.]
J.M. McKenzie, M. Zakarjia.
Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.
Thyroid, 2 (1992), pp. 155-160
[13.]
A. Agustí.
Seguridad de los fármacos antitiroideos durante el embarazo.
Med Clin (Barc), 112 (1999), pp. 236
[14.]
S.J. Mandel, G.A. Brent, P.R. Larsen.
Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
Thyroid, 4 (1994), pp. 129-133
[15.]
N. Mitsuda, H. Tamaki, N. Amino, T. Hosono, K. Miyai, O. Tanizawa.
Risk factors for developmental disorders in infants born to women with Graves’ disease.
Obstet Gynecol, 80 (1992), pp. 359-364
[16.]
G.N. Burrow.
Neonatal goiter after maternal propylthiouracil therapy.
J Clin Endocrinol Metab, 25 (1965), pp. 403-408
[17.]
J.M. Khoury, J.E. Becerra, P.J. D’Almada.
Maternal thyroid disease and risk of birth defects in offspring: a population based case controlled study.
Paediatr Perinat Epidemiol, 3 (1989), pp. 402-420
[18.]
D.A. Wing, L.K. Millar, P.P. Koonings, M.N. Montoro, J.H. Mestman.
A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy.
Am J Obstet Gynecol, 170 (1994), pp. 90-95
[19.]
M. Clementi, E. Di Gianantonio, E. Pelo, I. Mammi, R.T. Basile, R. Tenconi.
Methimazole embryopathy: delineation of the phenotype.
Am J Med Genet, 83 (1999), pp. 43-46
[20.]
N. Momotani, J. Noh, H. Oyanagi, N. Ishikawa, K. Ito.
Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status.
N Engl J Med, 315 (1986), pp. 24-28
[21.]
N. Momotani, J. Noh, N. Ishikawa, K. Ito.
Relationship between silent thyroiditis and recurrent Graves’ disease in the postpartum period.
J Clin Endocrinol Metab, 79 (1994), pp. 285-289
[22.]
D.A. Fisher.
Fetal thyroid function: diagnosis and management of fetal thyroid disorders.
Clin Obstet Gynecol, 40 (1997), pp. 16-31
[23.]
F. Azizi.
Safety of methimazole in breastfeeding mothers.
J Pediatr, 128 (1996), pp. 855-857
[24.]
N. Momotani, R. Yamashita, M. Yoshimoto, J. Noh, N. Ishikawa, K. Ito.
Recovery from fetal hypothyroidism: evidence for the safety of breastfeeding while taking propylthiouracil.
Clin Endocrinol (Oxf), 31 (1989), pp. 591-595
[25.]
M.N. Montoro.
Management of hypothyroidism during pregnancy.
Clin Obstet Gynecol, 40 (1997), pp. 65-80
[26.]
K. Buckshee, A. Kriplani, A. Kapil, V.L. Bhargava, D. Takkar.
Hypothyroidism complicating pregnancy.
Aust N Z J Obstet Gynaecol, 32 (1992), pp. 240-242
[27.]
B. Lejeune, M. Leumune, J. Kinthae.
The epidemiology of autoimmune and functional thyroid disorders in pregnancy [abstract].
J Endocrinol Invest, 15 (1992), pp. 77
[28.]
R.Z. Klein, J.E. Haddow, J.D. Faix, R.S. Brown, R.J. Hermos, A. Pulkkinen, et al.
Prevalence of thyroid deficiency in pregnant women.
Clin Endocrinol, 35 (1991), pp. 41-46
[29.]
M.L. Fernández-Soto, A. González-Jiménez, F. Escobar-Jiménez.
Autoimmune thyroid disease during pregnancy and postpartum.
Endocrinologia, 46 (1999), pp. 295-301
[30.]
L.J. De Groot, P. Reed Larsen, G. Hennemann.
Thyroid disfunction in the pregnant patients.
The thyroid and its diseases. (6.a ed.), pp. 519-540
[31.]
R.E. Weiss, S. Balzano, N.H. Scherberg, S. Refetoff.
Neonatal detection of generalized resiscance to thyroid hormone.
J Am Med Assoc, 264 (1990), pp. 2245-2250
[32.]
J. Ginsberg, P.G. Walfish, D.J. Rafter, C. Von Westarp, R.M. Ehrlich.
Thyrotrophin blocking antibodies in the sera of mothers with congenitally hypothyroid infants.
Clin Endocrinol, 25 (1986), pp. 189-194
[33.]
U. Bogner, A. Gruters, B. Sigle, H. Helge, H. Schleusener.
Cytotoxic antibodies in congenital hypothyroidism.
J Clin Endocrinol Metab, 68 (1989), pp. 671-675
[34.]
N.R. Campbell, B.B. Hasinoff, H. Stalts, B. Rao, N.C. Wong.
Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism.
Ann Inten Med, 117 (1992), pp. 1010-1013
[35.]
L.A. Magee, E. Downar, M. Sermer, B.C. Boulton, L.C. Allen, G. Koren.
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Am J Obstet Gynecol, 172 (1995), pp. 1307-1311
[36.]
A.S. Leung, L.K. Millar, P.P. Koonings, M. Montoro, J.H. Mestman.
Perinatal outcome in hypothyroid pregnancies.
Obstet Gynecol, 81 (1993), pp. 349-353
[37.]
V.J. Pop, A.L. Van Baar, T. Vuslma.
Should all pregnant women be screened by hypothyroidism?.
Lancet, 354 (1999), pp. 1224-1225
[38.]
D. Glinoer.
The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology.
Endocr Rev, 18 (1997), pp. 404-433
[39.]
L.E. Davis, K.J. Leveno, F.G. Cunningham.
Hypothyroidism complicating pregnancy.
Obstet Gynecol, 72 (1988), pp. 108-112
[40.]
S. Bussen, T. Stek.
Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions.
Hum Reprod, 10 (1995), pp. 2938-2940
[41.]
D. Glinoer, M.L. Fernández-Soto, P. Bourdoux, B. Lejeune, F. Delange, M. Lemone.
Pregnancy in patients with mild thyroid anormalities: maternal and neonatal.
J Clin Endocrinol Metab, 73 (1991), pp. 421-427
[42.]
E. McCanlies, L.A. O’Leary, T.P. Foley, M.K. Kramer, J.P. Burke, A. Libman, et al.
Hashimoto’s thyroiditis and insulin dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function.
J Clin Endocrinol Metab, 83 (1998), pp. 1548-1551
[43.]
H.C. Gerstein.
Incidence of postpartum thyroid dysfunccion in patients with type 1 diabetes mellitus.
Ann Intern Med, 118 (1993), pp. 419-423
[44.]
M. Álvarez-Marfany, S.H. Roman, A.J. Drexler, C. Robertson, A. Stagnaro-Green.
Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus.
J Clin Endocrinol Metab, 79 (1994), pp. 10-16
[45.]
L. Fernández-Soto, A. González, J.A. Lobón, J.A. López, C. Pecerson, F. Escobar-Jiménez.
Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women.
Diabetes Care, 20 (1997), pp. 1524-1528
[46.]
W.S. Jones, E.B. Man.
Thyroid function in human pregnancy. VI: premature deliveries and reproductive failures of pregnant women with low serum butanol extractable iodines.
Am J Obstet Gynecol, 104 (1969), pp. 909-914
[47.]
H. Liu, N. Momotani, J.Y. Noh, N. Ishikawa, K. Takebe, K. Ito.
Maternal hypothyroidism during early pregnancy and intellectual development of the progeny.
Arch Intern Med, 154 (1994), pp. 785-787
[48.]
M. Montoro, J.V. Collea, S.D. Frasier, J.H. Mestman.
Successful outcome of pregnancy in women with hypothyroidism.
Ann Intern Med, 94 (1981), pp. 31-34
[49.]
J.E. Haddow, G.E. Palomaki, W.C. Allan, J.R. Williams, G.J. Knight, J. Gagnon, et al.
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological developement of the child.
N Engl J Med, 341 (1999), pp. 549-555
[50.]
G.N. Burrow, D.A. Fisher, P.R. Larsen.
Maternal and fetal thyroid function.
N Engl J Med, 331 (1994), pp. 1072-1078
[51.]
R.D. Utiger.
Maternal hypothyroidism and fetal developement.
N Engl J Med, 341 (1999), pp. 601-602
[52.]
G.A. Brent.
Maternal hypothyroidism: recognition and managent.
Thyroid, 9 (1999), pp. 661-665
[53.]
P.A. Singer, D.S. Cooper, G.H. Daniels, P.W. Laderson, F.S. Greenspan, E.G. Levy, et al.
Treatment guidelines for patients with thyroid nodules and welldifferentiated thyroid cancer.
Arch Intern Med, 156 (1996), pp. 2165-2172
[54.]
S. Feld, M. García, H.J. Baskin, R.H. Cobin, H. Gharib, I.D. Hay, et al.
AACE clinical practice guidelines for the diagnosis and management of thyroid nodules.
Endocr Pract, 2 (1996), pp. 78-84
[55.]
I.D. Hay, S. Feld, M. García, H.J. Baskin, D. Bergman, K. Burman, et al.
AACE clinical practice guidelines for the management of thyroid carcinoma.
Endocr Pract, 3 (1997), pp. 61-71
[56.]
M. Schlumberger.
Papillary and follicular thyroid carcinoma.
N Engl J Med, 338 (1998), pp. 297-306
[57.]
I.D. Hay.
Nodular thyroid disease diagnosed during pregnancy: how and when to treat.
Thyroid, 9 (1999), pp. 667-670
[58.]
G.H. Tan, H. Gharib, J.R. Goellner, J.A. Van Heerden, R.S. Bahn.
Management of thyroid nodules in pregnancy.
Arch Intern Med, 156 (1996), pp. 2317-2320
[59.]
D. Cortelazzi, D. Castagnone, B. Tassis, E. Venegoni, R. Rivolta, P. Beck-Peccoz.
Resolution of hyperthyroidism in a pregnant woman with toxic thyroid nodule by percutaneous ethanol injection.
Thyroid, 5 (1995), pp. 473-475
[60.]
K. Kobayaski, Y. Tanaka, S. Ishiguro, T. Mori.
Rapidly growing thyroid carcinoma during pregnancy.
J Surg Oncol, 55 (1994), pp. 61-64
[61.]
M. Moosa, E.L. Mazzaferi.
Outcome of differentiated cancer diagnosed in pregnant women.
J Clin Endocrinol Metab, 82 (1997), pp. 2862-2866
[62.]
J.H. Mestman, M. Goodwin, M.M. Montoro.
Thyroid disorders of pregnancy.
Endocrinol Metab Clin North Am, 24 (1995), pp. 41-71
[63.]
E.F. Marley, Y.C. Oertel.
Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women.
Diagn Cytophatol, 16 (1997), pp. 2317-2320
[64.]
I.B. Rosen, P.G. Walfish.
Pregnancy as a predisposing factor in thyroid neoplasia.
Arch Surg, 121 (1986), pp. 1287-1290
[65.]
I.B. Rosen, P.G. Walfish, V. Nikore.
Pregnancy and surgical thyroid disease.
Surgery, 98 (1985), pp. 1135-1140
[66.]
J.I. Hamburger.
Thyroid nodules in pregnancy.
Thyroid, 2 (1992), pp. 165-168
[67.]
C. Doherty, M. Shindo, D. Rice, M. Montero, J.H. Mestman.
Management of thyroid nodules during pregnancy.
Laryngoscope, 105 (1995), pp. 251-255
[68.]
I.B. Rosen, M. Korman, P.G. Walfish.
Thyroid nodular disease in pregnancy: current diagnosis and management.
Clin Obstet Gynecol, 40 (1997), pp. 81-89
[69.]
W. Choe, I.R. McDougall.
Thyroid cancer in pregnant women: diagnostic and therapeutic management.
Thyroid, 4 (1994), pp. 433-435
[70.]
S.S. Raab, J.F. Silverman, T.M. Elsheikh, P.A. Thomas, P.E. Wakely.
Pediatric thyroid nodules: disease, demographics and clinical management as determined by fine-needle aspiration biopsy.
Pediatrics, 95 (1995), pp. 46-49
[71.]
G. Radetti, C. Castellan, L. Tato, K. Platter, L. Gentili, S. Adami.
Bone mineral density in children and adolescent females treated with high doses of L-thyroxine.
Horm Res, 39 (1993), pp. 127-131
[72.]
L. Vini, S. Hyer, B. Pratt, C. Harmer.
Management of differentiated thyroid cancer diagnosed during pregnancy.
Eur J Endocrinol, 140 (1999), pp. 404-406
[73.]
C. Ayala, E. Navarro, J.R. Rodríguez, H. Silva, E. Venegas, R. Astorga.
Contraception after iodine-131 therapy for differentiated thyroid cancer.
Thyroid, 8 (1998), pp. 1009-1011
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
